VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 71 filers reported holding VERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $444,245 | +105.9% | 32,403 | +141.0% | 0.00% | – |
| Q2 2023 | $215,760 | +560.9% | 13,443 | +219.5% | 0.00% | – |
| Q1 2023 | $32,646 | +552.9% | 4,207 | +1721.2% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 231 | -32.7% | 0.00% | – |
| Q2 2022 | $5,000 | -92.8% | 343 | -88.4% | 0.00% | – |
| Q1 2022 | $69,000 | -54.6% | 2,955 | -48.1% | 0.00% | – |
| Q4 2021 | $152,000 | +15100.0% | 5,697 | +12021.3% | 0.00% | – |
| Q3 2021 | $1,000 | – | 47 | +67.9% | 0.00% | – |
| Q2 2021 | $0 | – | 28 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $40,289,000 | 12.90% |
| Kynam Capital Management, LP | 1,522,712 | $20,724,000 | 5.29% |
| Sofinnova Investments, Inc. | 3,181,442 | $43,299,000 | 3.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,825 | $281,057,000 | 2.93% |
| Octagon Capital Advisors LP | 575,000 | $7,826,000 | 2.09% |
| Vivo Capital, LLC | 666,666 | $9,073,000 | 0.91% |
| RA Capital Management | 1,578,820 | $21,488,000 | 0.57% |
| Alphabet Inc. | 301,580 | $4,105,000 | 0.22% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $219,000 | 0.11% |
| Polar Asset Management Partners Inc. | 294,300 | $4,005,000 | 0.05% |